FDA Adverse Event
Malfunction
Summary report: N
ADDITIONAL P MODULE
MDR report key: 1760904
·
Received July 12, 2007
Report
- Report Number
- 1823260-2007-06021
- Event Type
- Malfunction
- Date Received
- July 12, 2007
- Date of Event
- July 5, 2007
- Report Date
- July 12, 2007
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JFY
- PMA / PMN Number
- K953239
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Description of Event or Problem · 1
ON (B)(6) 2007, INITIAL CREATININE RESULT 240.5 UMOL/L. SAME SAMPLE REPEATED 4 DAYS LATER GAVE RESULT OF 97.5 UMOL/L. A NEW SAMPLE WAS TAKEN (B)(6) 2007 AND GAVE RESULT OF 86 UMOL/L. THE INITIAL SAMPLE WAS ALSO RETESTED ON (B)(6) 2007 USING DIFFERENT INSTRUMENT, USING 2 DIFFERENT METHODS AND GAVE RESULTS OF 94.7 UMOL/L AND 112 UMOL/L. IF ADDITIONAL INFORMATION IS RECEIVED, APPROPRIATE NOTIFICATION WILL BE PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ADDITIONAL P MODULE | CLINICAL CHEMISTRY ANALYZER - JJE | JFY | ROCHE DIAGNOSTICS | P MODULE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | IBUPROFEN| ENALAPID - 2X2.5 MG| HYDROCLOROTYRAZIET - 12.5 MG |